Patents Assigned to Illumina
-
Patent number: 12227791Abstract: Embodiments provided herein relate to methods and compositions for preparing nucleic acid libraries. Some embodiments include preparing libraries from nucleic acids obtained from degraded samples, such as ancient samples and fixed samples.Type: GrantFiled: November 1, 2022Date of Patent: February 18, 2025Assignee: Illumina, Inc.Inventors: Raquel Maria Sanches-Kuiper, Vincent Peter Smith, Sean Humphray
-
Patent number: 12227802Abstract: Embodiments of the present disclosure relate to nucleotide molecules with a 3? AOM blocking group. Also provided herein are methods to prepare such nucleotide molecules, and the uses of fully functionalized nucleotides containing the 3?-OH blocking group for sequencing applications.Type: GrantFiled: October 17, 2023Date of Patent: February 18, 2025Assignee: Illumina Cambridge LimitedInventors: Antoine Francais, Elena Cressina, Adam Culley, Angelica Mariani, Xiaolin Wu, Xiaohai Liu
-
Patent number: 12226767Abstract: An apparatus includes one or more valves adapted to be coupled to corresponding reagent reservoirs and a flow cell interface adapted to be coupled to a flow cell. The apparatus includes a sample cartridge interface having one or more ports and adapted to be coupled to a sample cartridge carrying a sample of interest. The sample cartridge interface positioned downstream of the flow cell interface. The apparatus includes a pump adapted to load a channel of the flow cell with the sample of interest via the flow cell interface associated with an outlet of the flow cell and a corresponding port of the sample cartridge interface.Type: GrantFiled: September 16, 2020Date of Patent: February 18, 2025Assignee: ILLUMINA, INC.Inventors: Bradley Drews, Reto Schoch, Tarun Khurana, Minsoung Rhee
-
Patent number: 12223651Abstract: Methods and systems for analysis of image data generated from various reference points. Particularly, the methods and systems provided are useful for real time analysis of image and sequence data generated during DNA sequencing methodologies.Type: GrantFiled: April 19, 2023Date of Patent: February 11, 2025Assignee: Illumina, Inc.Inventors: Francisco Jose Garcia, Klaus Maisinger, Stephen Tanner, John A. Moon, Tobias Mann, Michael Lawrence Parkinson, Anthony James Cox, Haifang H. Ge
-
Patent number: 12217832Abstract: The technology disclosed directly operates on sequencing data and derives its own feature filters. It processes a plurality of aligned reads that span a target base position. It combines elegant encoding of the reads with a lightweight analysis to produce good recall and precision using lightweight hardware. For instance, one million training examples of target base variant sites with 50 to 100 reads each can be trained on a single GPU card in less than 10 hours with good recall and precision. A single GPU card is desirable because it a computer with a single GPU is inexpensive, almost universally within reach for users looking at genetic data. It is readily available on could-based platforms.Type: GrantFiled: May 9, 2023Date of Patent: February 4, 2025Assignees: Illumina, Inc., Illumina Cambridge LimitedInventors: Ole Schulz-Trieglaff, Anthony James Cox, Kai-How Farh
-
Patent number: 12217403Abstract: Biosensor including an array of reaction sites and corresponding light sensors may experience crosstalk in which photons from one reaction site are detected by neighbors of its corresponding light sensor, and such crosstalk may be corrected using sharpening kernels corresponding to the sensors in the array. Such sharpening kernels may be derived from generative matrices, which themselves may be derived from point spread functions representing dispersion of illumination emitted from the reaction sites.Type: GrantFiled: June 27, 2022Date of Patent: February 4, 2025Assignee: ILLUMINA, INC.Inventor: Mohsen Rezaei
-
Patent number: 12217829Abstract: The technology disclosed relates to determining pathogenicity of variants. In particular, the technology disclosed relates to generating amino acid-wise distance channels for a plurality of amino acids in a protein. Each of the amino acid-wise distance channels has voxel-wise distance values for voxels in a plurality of voxels. A tensor includes the amino acid-wise distance channels and at least an alternative allele of the protein expressed by a variant. A deep convolutional neural network determines a pathogenicity of the variant based at least in part on processing the tensor. The technology disclosed further augments the tensor with supplemental information like a reference allele of the protein, evolutionary conservation data about the protein, annotation data about the protein, and structure confidence data about the protein.Type: GrantFiled: April 15, 2021Date of Patent: February 4, 2025Assignee: Illumina, Inc.Inventors: Tobias Hamp, Hong Gao, Kai-How Farh
-
Patent number: 12216741Abstract: The technology disclosed corrects inter-cluster intensity profile variation for improved base calling on a cluster-by-cluster basis. The technology disclosed accesses current intensity data and historic intensity data of a target cluster, where the current intensity data is for a current sequencing cycle and the historic intensity data is for one or more preceding sequencing cycles. A first accumulated intensity correction parameter is determined by accumulating distribution intensities measured for the target cluster at the current and preceding sequencing cycles. A second accumulated intensity correction parameter is determined by accumulating intensity errors measured for the target cluster at the current and preceding sequencing cycles. Based on the first and second accumulated intensity correction parameters, next intensity data for a next sequencing cycle is corrected to generate corrected next intensity data, which is used to base call the target cluster at the next sequencing cycle.Type: GrantFiled: November 3, 2023Date of Patent: February 4, 2025Assignee: Illumina, Inc.Inventors: Eric Jon Ojard, Abde Ali Hunaid Kagalwalla, Rami Mehio, Nitin Udpa, Gavin Derek Parnaby, John S. Vieceli
-
Patent number: 12217831Abstract: The technology disclosed assigns quality scores to bases called by a neural network-based base caller by (i) quantizing classification scores of predicted base calls produced by the neural network-based base caller in response to processing training data during training, (ii) selecting a set of quantized classification scores, (iii) for each quantized classification score in the set, determining a base calling error rate by comparing its predicted base calls to corresponding ground truth base calls, (iv) determining a fit between the quantized classification scores and their base calling error rates, and (v) correlating the quality scores to the quantized classification scores based on the fit.Type: GrantFiled: April 5, 2023Date of Patent: February 4, 2025Assignee: Illumina, Inc.Inventors: Kishore Jaganathan, John Randall Gobbel, Amirali Kia
-
Patent number: 12212554Abstract: Flexible authentication technologies customized to particular tenants of a data center network can be implemented. For example, an administrator can specify a primary authentication server and specify at which data centers different applications are to be hosted for a given tenant. End users can be shielded from the complexities of implementing such configuration details. For example, single sign-on authentication can be implemented, even when applications are configured to be hosted in different data centers. Enterprise tenants can thus control where applications are hosted and enforce data containment scenarios without encumbering users with additional tasks. Collaboration and application-to-application authentication can be achieved.Type: GrantFiled: May 22, 2023Date of Patent: January 28, 2025Assignee: Illumina, Inc.Inventors: Milan Karangutkar, Prabhu Palanisamy, Satnam Alag
-
Generating nucleic acids with modified bases using recombinant terminal deoxynucleotidyl transferase
Patent number: 12209266Abstract: Disclosed herein include methods of generating a single stranded deoxyribonucleic acid (ssDNA) scaffold comprising nucleotides with modified bases using a recombinant terminal deoxynucleotidyl transferase (TdT). The recombinant TdT can comprise an amino acid sequence that is at least 80% identical to a Bos taurus TdT, or a fragment thereof, and for example comprise one or more amino acid substitution mutations at one or more positions functionally equivalent to Glu191, Lys193, Glu194, Asp242, Lys287, Phe296, Met299, Thr342, and His420 in the Bos taurus TdT.Type: GrantFiled: May 11, 2021Date of Patent: January 28, 2025Assignees: Illumina, Inc., Illumina Singapore Pte. Ltd.Inventors: Saurabh Rajendra Nirantar, Sergio Peisajovich, Eric Brustad -
Patent number: 12209575Abstract: Actuation systems and methods are disclosed. An apparatus includes a system including a flow cell receptacle and a valve drive assembly including a shape memory alloy actuator including a pair of shape memory alloy wires and a flow cell disposable within the flow cell receptacle and having a membrane valve. The system actuates the membrane valve, via the shape memory alloy actuator, by causing a voltage to be applied to a first one of the shape memory alloy wires and the system not applying the voltage to a second one of the shape memory alloy wires.Type: GrantFiled: October 20, 2023Date of Patent: January 28, 2025Assignee: ILLUMINA, INC.Inventors: Reto Schoch, Xuance Zhou, Tarun Khurana, Chetanya Jain, Gregory Suematsu
-
Patent number: 12201985Abstract: Devices, systems, and methods for non-volatile storage include a well activation device operable to modify one or more wells from a plurality of wells of a flow cell to provide a set of readable wells. Readable wells are configured to allow exposure of a well to substances from nucleotide sequencing fluids, and prevent exposure to other substances and fluids, such as nucleotide synthesizing fluids. The well activation device may also modify wells to provide a set of writeable wells. This set of wells is configured to allow exposure to the nucleotide synthesizing fluids and substances; and prevent exposure to the nucleotide sequencing fluids and substances. There may also be provisions made for risk mitigation for data errors such as generating commands to write specified data to a nucleotide sequence associated with a particular location in a storage device, reading the nucleotide sequence and performing a comparison.Type: GrantFiled: January 31, 2023Date of Patent: January 21, 2025Assignee: Illumina, Inc.Inventors: Merek Siu, Ali Agah, Stanley Hong, Tarun Khurana, Aathavan Karunakaran, Craig Ciesla, Amirali Kia
-
Patent number: 12202950Abstract: Some embodiments described herein relate to a substrate with a surface comprising a silane or a silane derivative covalently attached to optionally substituted cycloalkene or optionally substituted heterocycloalkene for direct conjugation with a functionalized molecule of interest, such as a polymer, a hydrogel, an amino acid, a nucleoside, a nucleotide, a peptide, a polynucleotide, or a protein. In some embodiments, the silane or silane derivative contains optionally substituted norbornene or norbornene derivatives. Method for preparing a functionalized surface and the use in DNA sequencing and other diagnostic applications are also disclosed.Type: GrantFiled: March 27, 2023Date of Patent: January 21, 2025Assignee: Illumina, Inc.Inventors: Lorenzo Berti, Andrew A. Brown, Wayne N. George
-
Patent number: 12204086Abstract: A method is used to generate a distortion model for a structured illumination microscopy (SIM) optical system. A sliding window is moved in relation to a plurality of images to define a plurality of sub-tiles. Each sub-tile represents a portion of the corresponding image. Parameters are estimated for each sub-tiles. The parameters include two or more parameters selected from the group consisting of modulation, angle, spacing, phase offset, and phase deviation. A full width at half maximum (FWHM) value associated with each sub-tile is estimated. A distortion model is estimated, based at least in part on a combination of the estimated parameters and FWHM values stored in the predetermined format and an estimated center window parameter. A two-dimensional image may be generated, based at least in part on the estimated distortion model. The two-dimensional image may include representations indicating where distortions occur in the optical system.Type: GrantFiled: August 21, 2023Date of Patent: January 21, 2025Assignee: ILLUMINA, INC.Inventors: Robert Langlois, Bo Lu, Hongji Ren, Joseph Pinto, Simon Prince, Austin Corbett
-
Patent number: 12203076Abstract: The present invention relates to a method for introducing mutations into at least one target nucleic acid molecule comprising (a) providing at least one sample comprising at least one target nucleic acid molecule; and (b) amplifying the at least one target nucleic acid molecule using a low bias DNA polymerase. The present further relates to a use of a low bias DNA polymerase in a method for introducing mutations into one or more nucleic acid molecule(s), a group of sample tags, a method for designing the group of sample tags, a computer readable medium, and a method for preferentially amplifying target nucleic acid molecules.Type: GrantFiled: June 20, 2022Date of Patent: January 21, 2025Assignee: Illumina Singapore Pte. Ltd.Inventors: Leigh G. Monahan, Joyce To, Catherine Maree Burke, Michael Imelfort, Aaron Earl Darling
-
Patent number: 12195798Abstract: Presented are methods and compositions for obtaining sequence information from one or more individual cells. The methods are useful for obtaining sequence information for a single nucleotide sequence, and for multiplex generation of sequence information from one or more individual cells.Type: GrantFiled: September 28, 2020Date of Patent: January 14, 2025Assignees: Illumina, Inc., The Regents of the University of CaliforniaInventors: Jian-Bing Fan, Kun Zhang
-
Patent number: 12195796Abstract: Embodiments of the present disclosure relate to cyclooctatetraene containing dyes and their uses as fluorescent labels. Also provided are composition containing cyclooctatetraene. The dyes and compositions may be used in various biological applications, such as nucleic acid sequencing.Type: GrantFiled: May 2, 2023Date of Patent: January 14, 2025Assignee: Illumina Cambridge LimitedInventors: Xiaolin Wu, Xiaohai Liu, Nikolai Nikolaevich Romanov, Antoine Francais, Patrick McCauley, Michael Callingham, Carole Anastasi
-
Patent number: D1059390Type: GrantFiled: September 25, 2022Date of Patent: January 28, 2025Assignee: Illumina, Inc.Inventors: Gordana Lamb, Nahida Badran, Jacob Dessau, Jack Godfrey Wood, Raymond Lawrence Oyung, John Tate Sager
-
Patent number: D1061555Type: GrantFiled: September 25, 2022Date of Patent: February 11, 2025Assignee: Illumina, Inc.Inventors: Gordana Lamb, Nahida Badran, Jacob Dessau, Jack Godfrey Wood, Raymond Lawrence Oyung, John Tate Sager